Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
about
Emerging immunotherapies for glioblastomaIsocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With GlioblastomasDendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.IDH mutational status and the immune system in gliomas: a tale of two tumors?Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
P2860
Q37025105-70AC4A26-6413-4806-82E3-A51F3337470EQ38843549-80BD2B14-B128-4285-914A-4E9A4DB0AF74Q38912265-62ADD1EC-D7DA-407C-A3DF-4373D4F0308BQ47103832-9F7E750A-20FF-493B-8AE6-B486E9FDF935Q47146223-1D879F85-3413-404A-8317-C346112714E9Q47957409-52F42A6F-E0AB-45A2-A3F0-EA0220C19C1DQ48428684-5235C976-B5BD-4A8A-8053-66329A71142AQ48472939-516B92E8-9E16-4664-B46B-E7DC32FCCBE5
P2860
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
@en
type
label
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
@en
prefLabel
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
@en
P2093
P2860
P356
P1476
Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review
@en
P2093
Bryan D Choi
John H Sampson
Tiffany R Hodges
P2860
P304
P356
10.3171/2013.3.JNS122282
P407
P577
2013-04-12T00:00:00Z